Abstract
Ribonucleotides (NTP) and deoxyribonucleotides (dNTP) are the basic building blocks of RNA and DNA. While the major nucleotides are found in all mammalian cells their relative pool sizes are quite different depending on the cell type and species. These unique nucleotide pool patterns are maintained to a large extent, by the tightly regulated biosynthetic and metabolic pathways through a number of feedback controls. Disruption of these balances have been shown to have profound effects on DNA synthesis and replication in cultured cells (Ashman and Davidson 1981; Topal and Baker 1982; Das et al. 1983; Newman and Miller 1983; Meuth 1984; Nicander and Reichard 1985; Yosmoka et al. 1987; Phear and Meuth 1989; Kohalmi et al. 1991; Wataya et al. 1993). In fact, this biological feature has become a fundamental tenet for the design of chemotherapeutic agents in the past half century.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abbott BD, Lau C, Buckalew AR, Logsdon TR, Setzer W, Zucker RM, Elstein KH, Kavlock RJ (1993) Effects of 5-fluorouracil on embryonic rat palate in vitro: fusion in the absence of proliferation. Teratology 47: 541–554
Abonyi M, Prajda N, Hata Y, Nakamura H, Weber G (1992) Methotrexate decreases thymidine kinase activity. Biochem Biophys Res Commun 187: 522–528
Adhami H (1979) Influence of 6-mercaptopurine on the prenatal development of the ratcortex. Z Mikrosk Anat Forsch 93: 21–32
Adlard BPF, Dobbing J, Sands J (1975) A comparison of the effects of cytosine ara-binoside and adenine arabinoside on some aspects of brain growth and development in the rat. Br J Pharmacol 54: 33–39
Akazawa S, Kumai R, Yoshida K, Ayusawa D, Shimizu K, Seno T (1986) The cytotoxicity of 5-fluorouracil is due to its incorporation into RNA and not its inhibition of thymidylate synthase as evidenced by the use of a mouse cell mutant deficient in thymidylate synthase. Jpn J Cancer Res 77: 620–624
Airhart MJ, Robbins CM, Knudsen TB, Church JK, Skalko RG (1993) Occurrence of embryotoxicity in mouse embryos following in utero exposure to 2′-deoxy-coformycin (pentostatin). Teratology 47: 17–27
Amemiya K, Keen CL, Hurley LS (1986) 6 Mercaptopurine-induced alterations in mineral metabolism and teratogenesis in the rat. Teratology 34: 321–334
Amemiya K, Hurely LS, Keen CL (1989) Effect of 6-mercaptopurine on 65Zn distribution in the pregnant rat. Teratology 39: 387–393
Arakawa T, Fujii M, Hayashi T (1967) Dilation of cerebral ventricles of rat offsprings induced by 6-mercaptopurine administration to dams. Tohoku J Exp Med 91: 143–148
Arezzo F (1987) Determination of ribonucleoside triphosphates and deoxy-ribonucleoside triphosphate in Novikoff hepatoma cells by high-performance liquid chromatography. Anal Biochem 160: 57–64
Aronow B, Lattier D, Silbiger R, Dusing M, Hutton J, Jones G, Stock J, McNeish J, Potter S, Witte D, Wiginton D (1989) Evidence for a complex regulatory array in the first intron of the human adenosine deaminase gene. Genes Dev 3: 1384–1400
Ashman CR, Davidson RL (1981) Bromodeoxyuridine mutagenesis in mammalian cells is related to deoxyribonucleotide pool imbalance. Mol Cell Biol 1: 254–260
Bagrij T, Kralovanszky J, Gyergyay F, Kiss E, Peters GJ (1993) Influences of uridine treatment in mice on the protection of gastrointestinal toxicity caused by 5-fluorouracil. Anticancer Res 13: 789–793
Bannigan JG (1985) The effects of 5-bromodeoxyuridine on fusion of the cranial neural folds in the mouse embryos. Teratology 32: 229—239
Bannigan JG, Langman J (1979) The cellular effect of 5-bromodeoxyuridine on the mammalian embryo. J Embryol Exp Morphol 36: 623–638
Bannigan JG, Langman J, van Breda A (1981) The uptake of 5-bromodeoxyuridine by the chicken embryo and its effects upon growth. Anat Embryol Bere 162: 425–434
Bannigan JG, Cottell DC, Morris A (1990) Study of the mechanisms of BUdR-induced cleft palate in the mouse. Teratology 42: 79–89
Ben-Khaial GS, Shah RM (1994) Effects of 5-fluorouracil on collagen synthesis in the developing palate of hamster. Anticancer Drugs 5: 99–104
Bhalla K, Tang C, Ibrado AM, Grant S, Tourkina E, Holladay C, Hughes M, Ma-honey ME, Huang Y (1992) Granulocyte-macrophage colony-stimulating factor/ interleukin-3 fusion protein (pIXY 321) enhances high dose ara-C-induced programmed cell death or apoptosis in human myeloid leukemia cells. Blood 80: 2883–2890
Blatt J, Mulvihill J J, Ziegler JL, Young RC, Poplack DG (1980) Pregnancy outcome following cancer chemotherapy. Am J Med 69: 828–832
Boike GM, Deppe G, Young JD, Malone JM, Malviya VK, Sokol RJ (1989) Chemotherapy in a pregnant rat model. 2. 5-Fluorouracil: nonlinear kinetics and placental transfer. Gynecol Oncol 34: 191–194
Bostrom B, Erdmann G (1993) Cellular pharmacology of 6-mercaptopurine in acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol 15: 80–86
Brach MA, Hermann F, Kufe DW (1992a) Activation of the AP-1 transcription factor by arabinofuranosylcytosine in myeloid leukemia cell. Blood 79: 728–734
Brach MA, Kharbanda SM, Hermann F, Kufe NW (1992b) Activation of the transcription factor kB in human KG-1 myeloid leukemia cells treated with 1-β-D-arabinofuranosylcytosine. Mol Pharmacol 41: 60–63
Bragonier JR, Carver MJ (1968) The influence of 6-mercaptopurine on rat placenta and fetus. Biochem Pharmacol 17: 1689–1697
Burdett DN, Shah RM (1988) Gross and cellular analysis of 6-mercaptopurine-induced cleft palate in hamster. Am J Anat 181: 179–194
Burdett DN, Waterfield JD, Shah RM (1988) Vertical development of the secondary palate in hamster embryos following exposure to 6-mercaptopurine. Teratology 37: 591–597
Caligiuri MA, Mayer RJ (1989) Pregnancy and leukemia. Semin Oncol 16: 388–396
Carson DA, Watson DB, Esparza LM, Carrera CJ, Kipps TJ, Cottam HB (1992) Oral antilymphocytic activity and induction of apoptosis by 2-chloro-2′-arabino-fluoro-2′-deoxyadenosine. Proc Natl Acad Sci USA 89: 2970–2974
Chaube S, Murphy ML (1968) The teratogenic effects of the recent drugs active in cancer chemotherapy. Adv Teratol 3: 181–237
Chaube S, Murphy ML (1973) Protective effect of deoxycytidylic acid (CdMP) on hydroxyurea-induced malformations in rats. Teratology 7: 79–88
Chaube S, Kreis W, Uchida K, Murphy ML (1968) The teratogenic effect of 1-β-D-arabinofuranosylcytosine in the rat. Protection by deoxycytidine. Biochem Pharmacol 17: 1213–1226
Chen B, Cyr DG, Hales BF (1994) Role of apoptosis in mediating phosphoramide mustard-induced rat embryo malformations in vitro. Teratology 50: 1–12
Cheng YC, Nakayama K (1983) Effects of 5-fluoro-2′-deoxyuridine metabolism in HeLa cells. Mol Pharmacol 23: 171–174
Chinsky JM, Ramamurphy Y, Fanslow WC, Ingolia DE, Blackburn MR, Shaffer KT, Higley HR, Trentin JJ, Rudolph FB, Knudsen TB, Kellems RE (1990) Developmental expression of adenosine deaminase in the upper alimentary tract of mice. Differentiation 42: 172–183
Chunduru SK, Appleman JR, Blakley RL (1993) Activity of human DNA polymerases α and β with 2-chloro-2/-deoxyadenosine S’-triphosphate as a substrate and quantitative effects of incorporation on chain extension. Arch Biochem Biophys 302: 19–30
Cory JG (1987) Unresolved issues in the study of mammalian ribonucleotide reductase. Adv Enzyme Regul 26: 287–299
Creinin MD (1993) Methotrexate for abortion at≤42 days gestation. Contraception 48: 519–525
Cross DR, Miller BJ, James SJ (1993) A simplified HPLC method for simultaneously quantifying ribonucleotides and deoxyribonucleotides in cell extracts or frozen tissues. Cell Proliferation 26: 327–336
Dagg CP (1960) Sensitive stages for the production of developmental abnormalities in mice with 5-fluorouracil. Am J Anat 106: 89–96
Dagg CP, Kallio E (1962) Teratogenic interaction of fluorodeoxyuridine and thymidine. Anat Rec 142: 301–302
Dagg CP, Doerr A, Offutt C (1966) Incorporation of 5-fluorouracil-2-C14 by mouse embryos. Biol Neonate 10: 32–46
Danenberg PV, Lockshin A (1981) Fiorina ted pyrimidines as tight-binding inhibitors of thymidylate synthetase. Pharmacol Ther 13: 69–90
Darab DJ, Minkoff R, Sciote J, Sulik KK (1987) Pathogenesis of median facial clefts in mice treated with methotrexate. Teratology 36: 77–86
Das SK, Benditt EP, Loeb LA (1983) Rapid changes in deoxynucleoside triphosphate pools in mammalian cells treated with mutagens. Biochem Biophys Res Commun 114: 458–464
Datta R, Kharbanda S, Kufe DW (1992) Transcriptional and post-transcriptional regulation of HI histone gene expression by 1-β-D-arabinofuranosylcytosine. Mol Pharmacol 41: 64–68
DeSesso JM, Goeringer GC (1990a) The nature of the embryo-protective interaction of propyl gallate with hydroxyurea. Reprod Toxicol 4: 145–152
DeSesso JM, Goeringer GC (1990b) Ethoxyquin and nordihydroguaiaretic acid reduce hydroxyurea developmental toxicity. Reprod Toxicol 4: 267–275
DeSesso JM, Goeringer GC (1991) Amelioration by leucovorin of methotrexate developmental toxicity in rabbits. Teratology 43: 201–215
DeSesso JM, Goeringer GC (1992) Methotrexate-induced developmental toxicity in rabbits is ameliorated by l-(ρ-tosyl)-3,4,4-trimethylimidazolidine, a functional analog for tetrahydrofolate-mediated one-carbon transfer. Teratology 45: 271–283
DeSesso JM, Jordan RL (1977) Drug-induced limb dysplaisas in fetal rabbits. Teratology 15: 199–211
DeSesso JM, Scialli AR, Goeringer GC (1994) D-mannitol, a specific hydroxyl free radical scavenger, reduces the developmental toxicity of hydroxyurea in rabbits. Teratology 49: 248–259
Doll DC, Ringenberg QS, Yarbro JW (1988) Management of cancer during pregnancy. Arch Intern Med 148: 2058–2064
Dolnick BJ, Pink JJ (1983) 5-Fluorouracil modulation of dihydrofolate reductase RNA levels in methotrexate-resistant KB cells. J Biol Chem 258: 13299–13306
Dolnick BJ, Pink J J (1985) Effects of 5-fluorouracil on dihydrofolate reductase and dihydrofolate reductase mRNA from methotrexate-resistant KB cells. J Biol Chem 260: 3006–3014
Doong S-L, Dolnick BJ (1988) 5-Fluorouracil substitution alters pre-mRNA splicing in vitro. J Biol Chem 263: 4467–4473
Dostal M, Jelinek R (1979) Embryotoxicity of transplacental and intraamniotically administered 6-azauridine in mice. Teratology 19: 143–148
Elstein KH, Zucker RM, Andrews JE, Ebron-McCoy M, Shuey DL, Rogers JM (1993a) Effects of developmental stage and tissue type on embryo/fetal DNA distributions and 5-fluorouracil-induced cell cycle perturbations. Teratology 48: 335–364
Elstein KH, Zucker RM, Shuey DL, Lau C, Chernoff N, Rogers JM (1993b) Utility of murine erythroleukemic cell (MELC) in assessing mechanisms of action of DNA-active developmental toxicants: application to 5-fluorouracil. Teratology 48: 75–87
Endo A, Sakai N, Ohwada K (1987) Analysis of diurnal difference in teratogen (Ara-C) susceptibility in mouse embryos by a progressive phase-shift method. Teratogenesis Carcinog Mutagen 7: 475–482
Eriksson S, Thelander L (1978) Allosteric regulation of calf thymus ribonucleotide reductase. Ciba Found Symp 68: 165–175
Feldkamp M, Carey JC (1993) Clinical teratology counseling and consultation case report: low dose methotrexate exposure in the early weeks of pregnancy. Teratology 47: 533–539
Forsthoefel PF, Williams ML (1975) The effects of 5-fluorouracil and 5-fluorodeoxy-uridine used alone and in combination with normal nucleic acid precursors on development of mice in lines selected for low and high expression of Strong’s luxoid gene. Teratology 11: 1–20
Franz J, Kleinebrecht J (1982) Teratogenic and clastogenic effects of BUdR in mice. Teratology 26: 195–202
Gao X, Blackburn MR, Knudsen TB (1994) Activation of apoptosis in early mouse embryos by 2’-deoxy adenosine exposure. Teratology 49: 1–12
Garrett C, Santi DV (1979) A rapid and sensitive high pressure liquid chromatography assay for deoxyribonucleoside triphosphates in cell extracts. Anal Biochem 99: 268–273
Goto T, Endo A (1987) Dose-and stage-related sex differences in the incidence of cytosine arabinoside induced digit anomalies in the mouse fetus. Teratology 35: 35–40
Grafton TF, Bazare JJ, Hansen DK, Sheehan DM (1987) The in vitro embryotoxicity of 5-fluorouracil in rat embryos. Teratology 36: 371–377
Gray LE, Kavlock RJ, Ostby J, Ferell J, Rogers J, Gray K (1986) An evaluation of figure-eight maze activity and general behavioral development following prenatal exposure to forty chemicals: effects of cytosine arabinoside, dinocap, nitrofen, and vitamin A. Neuro toxicology 7: 449–462
Grubb RB, Montiegel EC (1975) The teratogenic effects of 6-mercaptopurine on chick embryos in ovo. Teratology 11: 179–185
Gutova M, Elis J, Raskova H (1971) Teratogenic effect of 6-azauridine in rats. Teratology 4: 287–294
Handshumacher RE, Calabresi P, Welch AD, Bono VH, Fallon HJ, Frei E (1962) Summary of current information on 6-azauridine. Cancer Chemother Rep 21: 1–18
Herken R (1984) The influence of deoxycytidine monophosphate (dCMP) on the cytotoxicity of hydroxyurea in the embryonic spinal cord of the mouse. Teratology 30: 83–90
Herken R, Merker HJ, Krowke R (1978) Investigation of the effect of hydroxyurea on the cell cycle and the development of necrosis in the embryonic CNS of mice. Teratology 18: 103–118
Hirota Y, Yoshioka A, Tanaka S, Watanabe K, Otani T, Minowada J, Matsuda A, Ueda T, Wataya Y (1989) Imbalance of deoxyribonucleoside triphosphates, DNA double-strand breaks, and cell death caused by 2-chlorodeoxyadenosine in mouse FM3A cells. Cancer Res 49: 915–919
Hirsch KS, Hurley LS (1978) Relationship of dietary zinc to 6-mercaptopurine ter-atogenesis and DNA metabolism in the rat. Teratology 17: 303–314
Hunting D, Henderson JF (1981) Determination of deoxyribonucleoside triphosphates using DNA polymerase: a critical evaluation. Can J Biochem 59: 723–727
Hunting D, Henderson JF (1982) Models of the regulation of ribonucleotide reductase and their evaluation in intact mammalian cells. CRC Crit Rev Biochem 13: 325–348
Jackson RC (1992) The theoretical foundations of cancer chemotherapy introduced by computer models. Academic, San Diego
James SJ, Basnakian AG, Miller BJ (1994) In vitro folate deficiency induces deoxy-nucleotide pool imbalance, apoptosis, and mutagenesis in Chinese hamster ovary cells. Cancer Res 54: 5075–5080
Johnson EM, Chepenik KP (1981) Teratogenicity of folate antagonist. In: Juchau MR (ed) The biochemical basis of chemical teratogenesis. Elsevier/North-Holland, Amsterdam, pp 137–158
Jordan RL, Wilson JG, Schumacher HJ (1977) Embryotoxicity of the folate antagonist methotrexate in rats and rabbits. Teratology 15: 73–80
Karnofsky DA (1960) Influence of anti-metabolites inhibiting nucleic acid metabolism on embryonic development. Trans Assoc Am Physicians 73: 334—347
Karnofsky DA, Murphy ML, Lacon CR (1958) Comparative toxicologic and teratologic effects of 5-fluoro-substituted pyrimidines in the chick embryos and pregnant rat. Proc Am Assoc Cancer Res 2: 312–313
Kasubuchi Y, Wakaizumi S, Shimada M, Kusunoki T (1977) Cytosine arabinoside-induced transplacental dysgenetic hydrocephalus in mice. Teratology 16: 63–70
Katagiri N (1983) Vascular pattern and limb development. I. Normal development of the limbbud vasculature in the mouse and its aberrations induced by 5-fluoro-uracil. Hiroshima J Med Sci 32: 485–500
Kay AC, Saven A, Carrera CJ, Carson DA, Thurston D, Beutler E, Piro LD (1992) 2-Chlorodeoxyadenosine treatment of low grade lymphomas. J Clin Oncol 10: 371–377
Khera KS (1976) Teratogenicity studies with methotrexate, aminopterin, and ace-tylsalicylic acid in domestic cats. Teratology 14: 21–28
Khera KS (1979) A teratogenicity study on hydroxyurea and diphenylhydantoin in cats. Teratology 20: 447–452
Klohs WD, Kraker AJ (1992) Pentostatin: future directions. Pharmacol Rev 44: 459–477
Knudsen TB, Ibrahim MM (1995) Co-specificity of nuclear p53 accumulation and apoptotic cell death in early mouse embryos following DNA damage. Teratology 51: 173
Knudsen TB, Kochhar DM (1981) Limb development in mouse embryo. III. Cellular events underlying the determination of altered skeletal patterns following treatment with 5’-fluoro-2 deoxyuridine. Teratology 23: 241–251
Knudsen TB, Green JD, Airhart MJ, Higley HR, Chinsky JM, Kellems RE (1988) Developmental expression of adenosine deaminase in placental tissues of the early postimplantation mouse embryo and uterine stroma. Biol Reprod 39: 937–951
Knudsen TB, Gray MK, Church MR, Blackburn MR, Airhart MJ, Kellems RE, Skalko RG (1989) Early postimplantation embryolethality in mice following in utero inhibition of adenosine deaminase with 2’-deoxycoformycin. Teratology 40: 615–626
Knudsen TB, Blackburn MR, Chinsky JM, Airhart MJ, Kellems RE (1991) Ontogeny of adenosine deaminase in the mouse decidua and placenta: immunolocalization and embryo transfer studies. Biol Reprod 44: 171–184
Knudsen TB, Winters RS, Obey SK, Blackburn MR, Airhart MJ, Church JK, Skalko RG (1992) Effects of (R)-deoxycoformycin (pentostatin) on intrauterine nucleoside catabolism and embryo viability in the pregnant mouse. Teratology 45: 91–103
Kochhar DM, Penner JD, McDay JA (1978) Limb development in mouse embryos. II. Reduction defects, cytotoxicity and inhibition of DNA synthesis produced by cytosine arabinoside. Teratology 18: 71–92
Kochhar DM, Penner JD, Knudsen TB (1980) Embryotoxic, teratogenic, and metabolic effects of ribavirin in mice. Toxicol Appl Pharmacol 52: 99–112
Kohalmi SE, Glattke M, Mcintosh EM, Kunz BA (1991) Mutational specificity of DNA precursor pool imbalance in yeast arising from deoxycytidine deaminase deficiency or treatment with thymidylate. J Mol Biol 220: 933–946
Kralovanszky J, Prajda N, Kerper-Fronius S, Bagrij T, Kiss E, Peters GJ (1993) Biochemical consequences of 5-fluorouracil gastrointestinal toxicity in rats: effect of high-dose uridine. Cancer Chemother Pharmacol 32: 243–248
Krowke R, Bochert G (1975) Inhibition of RNA synthesis, a possible mode of the embryotoxic action of hydroxyurea. Naunyn Schmiedebergs Arch Pharmacol 288: 7–16
Kury G, Chaube S, Murphy ML (1968) Teratogenic effect of some purine analogues on fetal rats. Arch Pathol 86: 395–102
Kwok JBJ, Tattersall MHN (1992) DNA fragmentation, dATP pool elevation and potentiation of antifolate cytotoxicity in LI210 cells by hypoxanthine. Br J Cancer 65: 503–508
Lau C, Cameron AM, Rogers JM, Shuey DL, Kavlock RJ (1992) Development of biologically-based dose-response models: correlations between developmental toxicity of 5-fluorouracil (5-FU) and its inhibition of thymidylate synthetase (TS) activity in the rat embryo. Teratology 45: 457
Le LV, Pizzuti DJ, Grenberg M, Reid R (1991) Accidental use of low-dose of 5-fluorouracil in pregnancy. J Reprod Med 36: 872–874
Lennard L (1992) The clinical pharmacology of 6-mercaptopurine. Eur J Clin Pharmacol 43: 329–339
Lindberg U, Skoog L (1970) A method for the determination of dATP and dTTP in picomole amounts. Anal Biochem 34: 152–160
Major PP, Egan E, Herrick D, Kufe DW (1982) 5-Fluorouracil incorporation into DNA of human breast carcinoma cells. Cancer Res 42: 3005–3009
Manson JM, Dourson ML, Smith CC (1977) Effects of cytosine arabinoside on in vivo and in vitro mouse limb development. In Vitro 13: 434–442
Marcickiewicz J, Chazan B, Niemiec T, Sokolska G, Troszynski M, Luczak M, Szmigielski S (1986) Microwave radiation enhances teratogenic effect of cytosine arabinoside in mice. Biol Neonate 50: 75–82
Merker HJ, Pospisil M, Mewes P (1975) Cytotoxic effects of 6-mercaptopurine on the limb-bud blastemal cells of rat embryos. Teratology 11: 199–218
Meuth M (1984) The genetic consequences of nucleotide precursor pool imbalance in mammalian cells. Mutat Res 126: 107–112
Millicovsky G, DeSesso JM (1980) Cardiovascular alterations in rabbit embryos in situ after a teratogenic dose of hydroxyurea: an in vivo microscopic study. Teratology 22: 115–124
Millicovsky G, DeSesso JM (1981) Effects of hydroxyurea on hemodynamics of pregnant rabbits: a maternally mediated mechanism of embryotoxicity. Am J Obstet Gynecol 140: 747–752
Mirkes PE, Greenway JC (1985) Uptake and binding of tritium from (chloroethyl 3H) cyclophosphamide by rat embryos in vitro. Teratology 31: 373–380
Mirkes PE, Ellison A, Little SA (1991) Resistance of rat embryonic heart cells to the cytotoxic effects of cyclophosphamide does not involve aldehyde dehydrogenase-mediated metabolism. Teratology 43: 307–318
Morrison PF, Allegra CJ (1989) Folate cycle kinetics in human breast cancer cells. J Biol Chem 264: 10552–10566
Nagomi H, Oohira A (1980) Experimental study on pathogenesis of Polydactyly of the thumb. J Hand Surg [Am] 5: 443–450
Nakada D Magasanik B (1964) The roles of inducer and catabolite repressor in the synthesis of P-galactosidase by Escherichia coli. J Mol Biol 8: 105–127
Nakashima K, Ninomiya H, Fujiki Y (1984) The effect of 5-bromodeoxyuridine on mouse embryos during neurulation in vitro. Experientia 40: 924–929
Nelson MM (1960) Teratogenic effects of pteroylglutamic acid deficiency in the rat. In: Wolstenholme GEW, O’Connor CM (eds) Ciba Foundation symposium on congenital malformations. Little and Brown, Boston, pp 134–157
Neubert D, Lessmollmann U, Hinz N, Dillmann I, Fuchs G (1977) Interference of 6-mercaptopurine riboside, 6-methyl-mercaptopurine riboside and azathioprine with the morphogenetic differentiation of mouse extremities in vivo and in organ culture. Naunyn Schmiedebergs Arch Pharmacol 298: 93–105
Newman CN, Miller JH (1983) Mutagen-induced changes in cellular deoxycytidine triphosphate and thymidine triphosphate in Chinese hamster ovary cells. Biochem Biophys Res Commun 114: 34–40
Nicander B, Reichard P (1985) Relations between synthesis of deoxyribonucleotides and DNA replication in 3T6 fibroblasts. J Biol Chem 260: 5376–5381
Nord LD, Martin DS (1991) Loss of murine tumor thymidine kinase activity in vivo following 5-fluorouracil (FUra) treatment by incorporation of FUra into RNA. Biochem Pharmacol 42: 2369–2375
Nord LD, Stolfi RL, Martin DS (1992) Biochemical modulation of 5-fluorouracil with leucovorin or delayed uridine rescue: correlation of antitumor activity with dosage and FUra incorporation into RNA. Biochem Pharmacol 43: 2543–2549
Odom LD, Plouffe L, Butler WJ (1990) 5-Fluorouracil exposure during the period of conception: report on two cases. Am J Obstet Gynecol 163: 76–77
Ohmori K (1972) Teratogenic effects of 5-fluoro-2/-deoxyuridine in pregnant mice. Teratology 5: 71–80
Ohno M (1984) Neuroanatomical study of somatomotor cortex in microcephalic mice induced by cytosine arabinoside. Brain Dev 6: 528–538
Olsen EA (1991) The pharmacology of methotrexate. J Am Acad Dermatol 25: 306–318
O’Neill KO, Shao X, Zhao Z, Malik A, Lee ML (1994) Capillary electrophoresis of nucleotides on Ucon-coated fused silica columns. Anal Biochem 222: 185–189
Ortega A, Puig M, Domingo JL (1991) Maternal and developmental toxicity of low doses of cytosine arabinoside in mice. Teratology 44: 379–384
Ostensen M (1992) Treatment with immunosuppressive and disease modifying drugs during pregnancy and lactation. Am J Reprod Immunol 28: 148–152
Parker WB, Cheng YC (1990) Metabolism and mechanism of action of 5-fluorouracil. Pharmacol Ther 48: 381–395
Percy DH (1975) Teratogenic effects of the pyrimidine analogues 5-iododeoxyuridineand cytosine arabinoside in late fetal mice and rats. Teratology 11: 103–118
Phear G, Meuth M (1989) The genetic consequences of DNA precursor pool imbalance: sequence analysis of mutation induced by excess thymidine at the hamster aprt locus. Mutat Res 214: 201–206
Pinendo HM, Peters GFJ (1988) Fluorouracil: biochemistry and pharmacology. J Clin Oncol 6: 1653–1664
Plunkett W, Saunders PP (1991) Metabolism and action of purine nucleoside analogs. Pharmacol Ther 49: 239–268
Prescott DM (1976) Reproduction of eukaryotic cells. Academic, New York Reichard P (1985) Ribonucleotide reductase and deoxyribonucleotide pools. Basic Life Sci 31: 33–45
Reimers TJ, Sluss PM (1978) 6-Mercaptopurine treatment of pregnant mice: effects on second and third generations. Science 201: 65–67
Rhee MS, Coward KJ, Galivan J (1992) Depletion of 5,10-methylenetetrahydrofolate and 10-formyltetrahydrofolate by methotrexate in cultured hepatoma cells. Mol Pharmacol 42: 909–916
Ritter EJ (1984) Potentiation of teratogenesis. Fund Appl Toxicol 4: 352–359
Ritter EJ, Bruce LM (1979) The quantitative determination of deoxyribonucleoside triphosphates using high performance liquid chromatography. Biochem Med 21: 16–21
Ritter EJ, Scott WJ, Wilson JG (1971) Teratogenesis and inhibition of DNA synthesis induced in rat embryos by cytosine arabinoside. Teratology 4: 7–14
Ritter EJ, Scott WJ, Wilson JG (1973) Relationship of temporal patterns of cell death and development to malformations in the rat limb. Possible mechanisms of ter-atogenesis with inhibitors of DNA synthesis. Teratology 7: 219–226
Ritter EJ, Scott WJ, Wilson JG, Lampkin BC, Neely JE (1980) Effect of 5-fluoro-2’-deoxyuridine on deoxyribonucleotide pools in vivo. J Natl Cancer Inst 65: 603–605
Robertson LE, Chubb S, Meyn RE, Story M, Ford R, Hittleman WN, Plunkett W (1993) Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2’-deoxyadenosine and 9-β-D-arabinosyl-2-fluoroadenine. Blood 81: 143–150
Rosen R, Rothman F, Weigert MG (1969) Miscoding caused by 5-fluorouracil. J Mol Biol 44: 363–375
Ross DD, Cuddy DP, Cohen N, Hensley DR (1992) Mechanistic implications of alterations in HL-60 cell nascent DNA after exposure to 1-β-D-arabinofu-ranosylcytosine. Cancer Chemother Pharmacol 31: 61–70
Ruffolo P, Ferm V (1965) The embryocidal and teratogenic effects of 5-bromodeoxy-uridine in the pregnant hamster. Lab Invest 14: 1547–1553
Saksena SK, Chaudhury RR (1970) The antifertility effect of 2’,3’,5’,-tri-0-acetyl-6-azauridine. Part II. In rabbits. Indian J Med Res 58: 374–376
Santelli G, Valeriote F (1980) In vivo potentiation of 5-fluorouracil cytotoxicity against AKR leukemia by purine, pyrimidines, and their nucleosides and deoxynucleo-sides. J Natl Cancer Inst 64: 69–72
Santi DV, McHenry CS, Sommer S (1974) Mechanism of interaction of thymidylate synthetase with 5-fluorouridylate. Biochemistry 13: 471–480
Saunders MA, Wiesner BP, Yudkin J (1961) Control of fertility by 6-azauridine. Nature 189: 1015–1016
Schafer AI (1981) Teratogenic effects of antileukemic chemotherapy. Arch Intern Med 141: 514—515
Schmid BP (1984) Monitoring of organ formation in rat embryos after in vitro exposure to azathioprine, mercaptopurine, methotrexate or cyclosporin A. Toxicology 31: 9–21
Schmid P, Lorenz A, Hameister H, Montenarh M (1991) Expression of p53 during mouse embryogenesis. Development 113: 857–865
Schuetz JD, Wallace HJ, Diasio RB (1984) 5-Fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity. Cancer Res 44: 1358–1363
Schumacher HJ, Wilson JG, Jordan RL (1969) Potentiation of the teragenic effects of 5-fluorouracil by natural pyrimidines. II. Biochemical aspects. Teratology 2: 99–106
Scott JR (1977) Fetal growth retardation associated with maternal administration of immunosuppressive drugs. Am J Obstet Gynecol 128: 668–674
Scott WJ (1977) Cell death and reduced proliferative rate. In: Wilson JG, Fraser FC (eds) Mechanisms and pathogenesis. Plenum, New York, pp 81–98 (Handbook of teratology, vol 2)
Scott WJ (1981) The pathogenesis of bromodeoxyuridine induced Polydactyly. Teratology 23: 383–389
Scott WJ, Ritter EJ, Wilson JG (1975) Studies on induction of Polydactyly in rats with cytosine arabinoside. Dev Biol 45: 103–111
Scott WJ, Ritter EJ, Wilson JG (1980) Ectodermal and mesodermal cell death patterns in 6-mercaptopurine riboside-induced digital deformities. Teratology 21: 271–279
Shah RM, Burdett DN (1978) Developmental abnormalities induced by 6-mercaptopurine in the hamster. Can J Physiol Pharmacol 57: 53–58
Shah RM, MacKay RA (1978) Teratological evaluation of 5-fluorouracil and 5-bromo-2-deoxyuridine on hamster fetuses. J Embryol Exp Morphol 43: 47–54
Shah RM, Wong DTW (1980) Morphological study of cleft palate development in 5-fluorouracil-treated hamster fetuses. J Embryol Exp Morphol 57: 119–128
Shah RM, Wong DT, Suen RS (1984) Ultrastructural and cytochemical observations on 5-fluorouracil-induced cleft-palate development in hamster. Am J Anat 170: 567–580
Shah RM, Chen YP, Burdett DN (1989) Palatal shelf reorientation in hamster embryos following treatment with 5-fluorouracil. Histol Histopathol 4: 449–456
Shuey DL, Lau C, Logsdon TR, Zucker RM, Elstein KH, Narotsky MG, Setzer W, Kavlock RJ, Rogers JM (1994a) Biologically based dose-response modeling in developmental toxicology: biochemical and cellular sequelae of 5-fluorouracil exposure in the developing rat. Toxicol Appl Pharmacol 126: 129–144
Shuey DL, Zucker ZM, Elstein KH, Rogers JM (1994b) Fetal anemia following maternal exposure to 5-fluorouracil in the rat. Teratology 49: 311–319
Shuey DL, Buckalew AR, Wilke TS, Rogers JM, Abbott BD (1994c) Early events following maternal exposure to 5-fluorouracil lead to dysmorphology in cultured embryonic tissues. Teratology 50: 379–386
Simpson RC, Brown PR (1986) High-performance liquid chromatographic profiling of nucleic acid components in physiological samples. J Chromatogr 379: 269–311
Skalko RG, Gold MP (1974) Teratogenicity of methotrexate in mice. Teratology 9: 159–164
Skalko RG, Jacobs DM (1978) The effects of 5-fluorouracil on [3H]nucleoside incorporation into DNA of mouse embryos and maternal tissues. Exp Mol Pathol 29: 303–315
Skalko RG, Packard DS (1973) The teratogenic response of the mouse embryo to 5-iododeoxyuridine. Experientia 29: 198–200
Skalko RG, Packard DS (1975) Mechanisms of halogenated nucleoside embryo-toxicity. Ann NY Acad Sci 255: 552–558
Skalko RG, Packard DS, Schwendimann RN, Raggio JF (1971) The teratogenic response of mouse embryos to 5-bromodeoxyuridine. Teratology 4: 87–93
Skoda J (1975) Azapyrimidine nucleotides. In: Eichler O, Farah H, Herken H, Welch AD (eds) Handbook of experimental pharmacology, vol 38. Springer, Berlin Heidelberg New York, pp 348–372
Skoog L (1970) An enzymatic method for the determination of dCTP and dGTP inpicomole amounts. Eur J Biochem 17: 202–208
Skoog L, Nordenskjold B (1971) Effects of hydroxyurea and 1-β-D-arabinofuranosyl-cytosine on deoxyribonucleotide pools in mouse embryo cells. Eur J Biochem 19: 81–91
Skoog KL, Nordenskjold BA, Bjursell KG (1973) Deoxyribonucleoside-triphosphate pools and DNA synthesis in synchronized hamster cells. Eur J Biochem 33: 428–432
Skoog KL, Bjursell KG, Nordenskjold BA (1974) Cellular deoxyribonucleotide triphosphate pools levels and DNA synthesis. Adv Enzyme Regul 12: 345–354
Snow MHL (1983) Restorative growth in mammalian embryos. In: Kalter H (ed) Issues and reviews in teratology, vol 1. Plenum, New York, pp 251–284
Snow MHL (1986) Uncoordinated development of embryonic tissue following cytotoxic damage. In: Welsch F (ed) Approaches to elucidate mechanisms in ter-atogenesis. Hemisphere, Washington, pp 83–98
Snow MHL, Tam PPL (1979) Is compensatory growth a complicating factor in mouse teratology? Nature 279: 555–557
Solter AW, Handschumacher RE (1969) A rapid quantitative determination of deoxyribonucleoside triphosphates based on the enzymatic synthesis of DNA. Biochim Biophys Acta 174: 585–590
Stadler HE, Knowles J (1971) Fluorouracil in pregnancy: effect on the neonate. JAMA 217: 214–215
Stephens JD, Golbus MS, Miller TR, Wilber RR, Epstein CJ (1980) Multiple congenital anomalies in a fetus exposed to 5-fluorouracil during the first trimester. Am J Obstet Gynecol 137: 747–749
Stolfi RL, Colofiore JR, Nord LD, Koutcher JA, Martin DS (1992) Biochemical modulation of tumor cell energy: regression of advanced spontaneous murine breast tumors with a 5-fluorouracil-containing drug combination. Cancer Res 52: 4074–4081
Stovall TG, Ling FW, Buster JE (1990) Reproductive performance after methotrexatetreatment of ectopic pregnancy. Am J Obstet Gynecol 162: 1620–1624
Takigiku R, Schneider RE (1991) Reproducibility and quantitation of separation for ribonucleoside triphosphates and deoxyribonucleoside triphosphates by capillary zone electrophoresis. J Chromatogr 559: 247–256
Takimoto CH, Voeller DB, Strong JM, Anderson L, Chu E, Allegra CJ (1993) Effects of 5-fluorouracil substitution on the RNA conformation and in vitro translation of thymidylate synthase messenger RNA. J Biol Chem 268: 21438–21442
Tanaka K, Yoshioka A, Tanaka S, Wataya Y (1984) An improved method for the quantitative determination of deoxyribonucleoside triphosphates in cell extracts. Anal Biochem 139: 35–41
Thiersch JB (1952) Therapeutic abortions with a folic acid antagonist, 4-aminoter-oylglutamic acid (4-amino P.G.A.). Am J Obstet Gynecol 63: 1298–1304
Topal MD, Baker MS (1982) DNA precursor pool: a significant target for N-methyl-N-nitrosourea in C3H/10T1/2 clone 8 cells. Proc Natl Acad Sci USA 79: 2211–2215
Tsukamoto I, Kojo S (1991) The effects of fluorouracil on thymidylate synthase and thymidine kinase in regenerating rat liver after partial hepatectomy. Biochim Biophys Acta 1074: 52–55
Valeriote F, Santelli G (1984) 5-Fluorouracil (5-FUra). Pharmacol Ther 24: 107–132
Van Wagenen G, DeConti RC, Handschumacher RE, Wade ME (1970) Abortifacient and teratogenic effects of triacetyl-6-azauridine in the monkey. Am J Obstet Gynecol 108: 272–281
Vorherr H, Welch AD (1970) The mode of interruption of pregnancy by 6-azauridine in mice and rats. Biochem Pharmacol 19: 1001–1006
Vojta M, Jirasek J (1966) 6-Azauridine-induced changes of the trophoblast in early human pregnancy. Clin Pharmacol Ther 7: 162–165
Wagner VM, Hill JS, Weaver D, Baehner RL (1980) Congenital abnormalities in baby born to cytarabine treated mother. Lancet 2: 98–99
Warkany J (1978) Aminopterin and methotrexate: folic acid deficiency. Teratology 17: 353–358
Warkany J (1986) Aminopterin and methotrexate: folic acid deficiency. In: Sever JL, Brent RL (eds) Teratology update: environmentally induced birth defect risks. Liss, New York, pp 39–43
Wataya Y, Hwang H, Nakazawa T, Takahashi K, Otani M, Igaki T (1993) Molecular mechanisms of cell death induced dNTP pool imbalance. Nucleic Acids Symp Ser 29: 109–110
Wilson JG (1971) Use of rhesus monkeys in teratological studies. Fed Proc 30: 104–109
Wilson JG (1973) Environment and birth defects. Academic, New York
Wilson JG, Jordan RL, Schumacher H (1969) Potentiation of the teratogenic effects of 5-fluorouracil by natural pyrimidines. I. Biological aspects. Teratology 2: 91–98
Wilson JG, Scott WJ, Ritter EJ, Fradkin R (1975) Comparative distribution and embryotoxicity of hydroxyurea in pregnant rats and rhesus monkeys. Teratology 11: 169–178
Wilson JG, Scott WJ, Ritter EJ, Fradkin R (1979) Comparative distribution and embryotoxicity of methotrexate in pregnant rats and rhesus monkeys. Teratology 19: 71–79
Wise LD, Scott WJ (1982) Incorporation of 5-bromo-2-deoxyuridine into mesenchymal limb-bud cells destined to die: relationship to Polydactyly induction in rats. J Embryol Exp Morphol 72: 125–141
Woodcock DM (1987) Cytosine arabinoside toxicity: molecular events, biological consequences, and their implications. Semin Oncol 2 Suppl 1: 251–256
Wubah JA, Ibrahim MM, Gao X, Nguyen D, Pisano MM, Knudsen TB (1996) Te-ratogen-induced eye defects mediated by p53-dependent apoptosis. Curr Biol 6: 60–69
Yarbro JW (1992) Mechanism of action of hydroxyurea. Semin Oncol 19 Suppl 9: 1–10
Yoshihara H, Dagg CP (1967) Teratogenicity of 6-azauridine in inbred mice. Anat Rec 157: 345
Yoshioka A, Tanaka S, Hiraoka O, Koyama Y, Hirota Y, Ayusawa D, Seno T, Garrett C, Wataya Y (1987) Deoxyribonucleoside triphosphate imbalance: 5-fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death. J Biol Chem 262: 8235–8241
Zucker RM, Elstein KH, Shuey DL, Rogers JM (1995) Flow cytometric detection of abnormal fetal erythropoiesis: application to 5-fluorouracil-induced anemia. Teratology 51: 37–44
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lau, C. (1997). Nucleotide Pool Imbalance. In: Kavlock, R.J., Daston, G.P. (eds) Drug Toxicity in Embryonic Development I. Handbook of Experimental Pharmacology, vol 124 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60445-4_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-60445-4_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64408-5
Online ISBN: 978-3-642-60445-4
eBook Packages: Springer Book Archive